Market Overview:
The global fluorescence-guided surgery systems market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cancer and other surgical procedures, technological advancements in fluorescence-guided surgery systems, and rising demand for minimally invasive surgeries. Based on type, the global fluorescence-guided surgery systems market can be segmented into open surgery and endoscopy. The open surgery segment is expected to account for a larger share of the global market than the endoscopy segment during the forecast period. This can be attributed to factors such as growing preference for open surgeries over minimally invasive surgeries and increasing incidence of cancer cases across the globe. Based on application, the global fluorescence-guided surgery systems market can be divided into cancer surgeries, cardiovascular surgeries, and other procedures (including neurosurgeries, orthopedic surgeries, etc.). Cancer surgeries are expected to account for a larger share of this market than other types of surgical procedures during the forecast period owing to rising prevalence rates of various types of cancers across different regions worldwide.
Product Definition:
A fluorescence-guided surgery system is a medical device that uses fluorescent dye to highlight cancerous tissue during surgery. This allows the surgeon to more easily remove all of the cancerous tissue, which improves the patient's prognosis.
Only for Open Surgery:
The global only for open surgery, it's usage and growth factor in Fluorescence-Guided Surgery (OFS) market size was valued at USD 6.5 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period. Increasing demand for minimally invasive surgeries coupled with increasing preference of patients towards fluorescence-guided surgery systems is primarily driving the growth of this market globally.
System for Endoscopy:
The global System for Endoscopy and it's usage in Fluorescence-Guided Surgery (SEGS) systems market size was valued at USD 4.5 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period. Increasing demand for minimally invasive surgeries, rising prevalence of chronic diseases such as cancer, gastrointestinal disorders & Parkinson’s disease among others are some high impact rendering drivers of this market.
Application Insights:
The others segment held the largest share of the market in 2017. This is attributed to growing adoption for fluorescence-guided surgeries for general laparoscopic procedures, such as endometriosis and adenomyosis. In addition, increasing number of research studies supporting its benefits over conventional imaging modalities are also expected to contribute towards growth during the forecast period.
Cancer surgeries segment is anticipated to witness lucrative growth during the forecast period due to rising prevalence of cancer across various parts of world coupled with technological advancements in oncology surgical procedures that require use of fluorescent tools. For instance, introduction of 4D Molecular Imaging by Thermodx Corporation offers real-time visualization by providing thermal and fluorescence images simultaneously through a single camera while enabling surgeons with enhanced accuracy and precision during cancer treatment procedures. Such factors are expected drive demand for these systems in near future.
Regional Analysis:
North America dominated the global market in 2017 owing to an increase in the prevalence of cancer and cardiovascular diseases, coupled with a rise in government initiatives. The region is expected to maintain its dominance over the forecast period due to continuous technological advancements and increasing adoption of advanced endoscopy procedures.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income, high unmet medical needs, and availability of effective treatment options for various diseases at low cost. Moreover, increasing investments by governments & private entities are expected favorably impact industry growth during the forecast period. For instance; In January 2016 ‘Make in India’ campaign was launched by Indian prime minister Narendra Modi which involved manufacturing activities within India itself instead of importing goods from other countries thus driving domestic manufacturers such as Medtronic plc., Johnson & Johnson Services Inc., Becton Dickerson And Company Inc.; thus positively impacting regional market growth over next few years.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global Fluorescence-Guided Surgery Systems market is expected to grow at a CAGR of over 7% during the forecast period. This can be attributed to the increasing demand for minimally invasive surgeries, which offer several benefits such as shorter hospital stays, reduced pain and blood loss, and faster recovery times.
- Rising prevalence of cancer: The incidence of cancer is rising globally due to factors such as aging population, unhealthy lifestyles, and environmental pollution. This is resulting in an increase in the demand for fluorescence-guided surgery systems for the treatment of various types of cancers.
- Technological advancements: The development of new fluorescence-guided surgery systems that are more efficient and user-friendly is likely to drive market growth during the forecast period. For instance, in 2017 Johnson & Johnson announced its plans to commercialize a next generation “smart” surgical system that uses artificial intelligence (AI) technology to improve accuracy and efficiency during tumor removal surgeries.
Scope Of The Report
Report Attributes
Report Details
Report Title
Fluorescence-Guided Surgery Systems Market Research Report
By Type
Only for Open Surgery, System for Endoscopy
By Application
Cancer Surgeries, Cardiovascular Surgeries, Others
By Companies
Stryker, Hamamatsu Photonics, Medtronic, Quest Medical Imaging, Shimadzu, Fluoptics, KARL STORZ
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
179
Number of Tables & Figures
126
Customization Available
Yes, the report can be customized as per your need.
Global Fluorescence-Guided Surgery Systems Market Report Segments:
The global Fluorescence-Guided Surgery Systems market is segmented on the basis of:
Types
Only for Open Surgery, System for Endoscopy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer Surgeries, Cardiovascular Surgeries, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Stryker
- Hamamatsu Photonics
- Medtronic
- Quest Medical Imaging
- Shimadzu
- Fluoptics
- KARL STORZ
Highlights of The Fluorescence-Guided Surgery Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Only for Open Surgery
- System for Endoscopy
- By Application:
- Cancer Surgeries
- Cardiovascular Surgeries
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fluorescence-Guided Surgery Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Fluorescence-guided surgery systems are medical devices that use fluorescent dyes to help surgeons see inside the body during surgery. The dye is injected into a vein before the operation, and it helps doctors see where they are cutting and how deep they are going. This technology can also help surgeons avoid making mistakes during surgeries.
Some of the key players operating in the fluorescence-guided surgery systems market are Stryker, Hamamatsu Photonics, Medtronic, Quest Medical Imaging, Shimadzu, Fluoptics, KARL STORZ.
The fluorescence-guided surgery systems market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Fluorescence-Guided Surgery Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Fluorescence-Guided Surgery Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Fluorescence-Guided Surgery Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Fluorescence-Guided Surgery Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Fluorescence-Guided Surgery Systems Market Size & Forecast, 2020-2028
4.5.1 Fluorescence-Guided Surgery Systems Market Size and Y-o-Y Growth
4.5.2 Fluorescence-Guided Surgery Systems Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Only for Open Surgery
5.2.2 System for Endoscopy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cancer Surgeries
6.2.2 Cardiovascular Surgeries
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Fluorescence-Guided Surgery Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Fluorescence-Guided Surgery Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Only for Open Surgery
9.6.2 System for Endoscopy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cancer Surgeries
9.10.2 Cardiovascular Surgeries
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Only for Open Surgery
10.6.2 System for Endoscopy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cancer Surgeries
10.10.2 Cardiovascular Surgeries
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Only for Open Surgery
11.6.2 System for Endoscopy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cancer Surgeries
11.10.2 Cardiovascular Surgeries
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Only for Open Surgery
12.6.2 System for Endoscopy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cancer Surgeries
12.10.2 Cardiovascular Surgeries
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Only for Open Surgery
13.6.2 System for Endoscopy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cancer Surgeries
13.10.2 Cardiovascular Surgeries
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Fluorescence-Guided Surgery Systems Market: Competitive Dashboard
14.2 Global Fluorescence-Guided Surgery Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Stryker
14.3.2 Hamamatsu Photonics
14.3.3 Medtronic
14.3.4 Quest Medical Imaging
14.3.5 Shimadzu
14.3.6 Fluoptics
14.3.7 KARL STORZ
